Using known clock-like mutational processes in each subtype, we inferred mutation timing of oncogenic drivers in broad periods of tumour evolution and calculated the mutation rates for each subtype that had a distinctive tumour evolution pattern. This evidence concerns the gene CLOCK and neoplasm.